Rhumbline Advisers I Teos Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 41,741 shares of ITOS stock, worth $343,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,741

Previous 44,861 6.95%

Holding current value

$343,528

Previous $665,000 35.94%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.09 - $17.97 $31,480 - $56,066	-3,120 Reduced 6.95%	41,741 $426,000
Q2 2024 Aug 01, 2024	BUY	$10.33 - $18.09 $36,289 - $63,550	3,513 Added 8.5%	44,861 $665,000
Q1 2024 May 09, 2024	BUY	$9.89 - $13.64 $11,413 - $15,740	1,154 Added 2.87%	41,348 $563,000
Q4 2023 Feb 08, 2024	SELL	$8.57 - $11.06 $246,841 - $318,561	-28,803 Reduced 41.75%	40,194 $440,000
Q3 2023 Nov 09, 2023	BUY	$10.95 - $14.6 $44,774 - $59,699	4,089 Added 6.3%	68,997 $755,000
Q2 2023 Aug 08, 2023	BUY	$12.93 - $18.05 $47,336 - $66,081	3,661 Added 5.98%	64,908 $859,000
Q1 2023 May 11, 2023	BUY	$13.02 - $22.62 $39,385 - $68,425	3,025 Added 5.2%	61,247 $834,000
Q4 2022 Feb 14, 2023	BUY	$17.77 - $21.6 $35,344 - $42,962	1,989 Added 3.54%	58,222 $1.14 Million
Q3 2022 Nov 10, 2022	BUY	$18.6 - $27.25 $108,661 - $159,194	5,842 Added 11.59%	56,233 $1.07 Million
Q2 2022 Aug 11, 2022	BUY	$16.57 - $35.1 $116,288 - $246,331	7,018 Added 16.18%	50,391 $1.04 Million
Q1 2022 May 12, 2022	BUY	$31.92 - $47.45 $513,880 - $763,897	16,099 Added 59.03%	43,373 $1.4 Million
Q4 2021 Feb 10, 2022	BUY	$26.23 - $47.86 $13,219 - $24,121	504 Added 1.88%	27,274 $1.27 Million
Q3 2021 Nov 12, 2021	BUY	$23.91 - $29.58 $14,585 - $18,043	610 Added 2.33%	26,770 $723,000
Q2 2021 Aug 05, 2021	BUY	$17.9 - $36.1 $135,932 - $274,143	7,594 Added 40.9%	26,160 $671,000
Q1 2021 May 06, 2021	BUY	$30.86 - $44.2 $248,083 - $355,323	8,039 Added 76.37%	18,566 $635,000
Q4 2020 Feb 10, 2021	BUY	$21.59 - $33.95 $40,481 - $63,656	1,875 Added 21.67%	10,527 $356,000
Q3 2020 Nov 12, 2020	BUY	$17.57 - $32.92 $152,015 - $284,823	8,652 New	8,652 $213,000

Others Institutions Holding ITOS

# of Institutions

165

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers I Teos Therapeutics, Inc. Transaction History